| scholarly article | Q13442814 |
| P50 | author | Roman Stilling | Q43115531 |
| Ivana Delalle | Q58276209 | ||
| Peter Falkai | Q58295323 | ||
| Andrea Schmitt | Q58315304 | ||
| Pooja Rao | Q59489957 | ||
| Dieter Edbauer | Q63092229 | ||
| P2093 | author name string | Laurent Farinelli | |
| Andre Fischer | |||
| Farahnaz Sananbenesi | |||
| Athanasios Zovoilis | |||
| Sanaz Bahari-Javan | |||
| Susanne Burkhardt | |||
| Roberto C Agis-Balboa | |||
| Hope Y Agbemenyah | |||
| P2860 | cites work | Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences | Q21092859 |
| A novel pathway regulates memory and plasticity via SIRT1 and miR-134 | Q24624906 | ||
| A mammalian microRNA expression atlas based on small RNA library sequencing | Q24644709 | ||
| A hippocampal Cdk5 pathway regulates extinction of contextual fear | Q24649571 | ||
| miR-34a repression of SIRT1 regulates apoptosis | Q24652720 | ||
| Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources | Q27860739 | ||
| Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 | ||
| Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? | Q27860893 | ||
| MicroRNAs: small RNAs with a big role in gene regulation | Q27860896 | ||
| Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide | Q28131750 | ||
| Using galaxy to perform large-scale interactive data analyses | Q28277397 | ||
| Age-Correlated Gene Expression in Normal and Neurodegenerative Human Brain Tissues | Q28749094 | ||
| The molecular biology of memory storage: a dialogue between genes and synapses | Q29547845 | ||
| A brain-specific microRNA regulates dendritic spine development | Q29614753 | ||
| SIRT1 is essential for normal cognitive function and synaptic plasticity | Q30496047 | ||
| Dissection of hippocampal dentate gyrus from adult mouse. | Q30890249 | ||
| The DIANA-mirExTra web server: from gene expression data to microRNA function | Q33531802 | ||
| Neuronal microRNA deregulation in response to Alzheimer's disease amyloid-beta | Q33605734 | ||
| Analysis of Alzheimer's disease severity across brain regions by topological analysis of gene co-expression networks | Q33711589 | ||
| Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles | Q33792982 | ||
| Mammalian microRNAs: experimental evaluation of novel and previously annotated genes | Q33839605 | ||
| Characterization of small RNAs in Aplysia reveals a role for miR-124 in constraining synaptic plasticity through CREB. | Q33873827 | ||
| Altered histone acetylation is associated with age-dependent memory impairment in mice. | Q34114011 | ||
| Gene regulation and DNA damage in the ageing human brain | Q34326236 | ||
| MiR-34, SIRT1 and p53: the feedback loop | Q34946471 | ||
| Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology | Q35016226 | ||
| Genomics of microRNA. | Q36381610 | ||
| MicroRNA expression in the adult mouse central nervous system | Q36470289 | ||
| Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression | Q36609033 | ||
| A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis | Q36678825 | ||
| Gene expression changes in the course of normal brain aging are sexually dimorphic | Q36926809 | ||
| Getting to the root of miRNA-mediated gene silencing | Q37055551 | ||
| Using hippocampal microRNA expression differences between mouse inbred strains to characterise miRNA function | Q37371867 | ||
| Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells | Q37487108 | ||
| Advantages of next-generation sequencing versus the microarray in epigenetic research | Q37522879 | ||
| Dysregulated microRNAs in neurodegenerative disorders | Q37676595 | ||
| Regulation of Myc by miR-34c: A mechanism to prevent genomic instability? | Q37770207 | ||
| MicroRNA functions in stress responses. | Q37802036 | ||
| Amyloid-β and tau--a toxic pas de deux in Alzheimer's disease | Q37824813 | ||
| Gene expression profile of the PDAPP mouse model for Alzheimer's disease with and without Apolipoprotein E. | Q38297749 | ||
| miRNA in situ hybridization in formaldehyde and EDC-fixed tissues | Q39612232 | ||
| MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251. | Q39703824 | ||
| p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC. | Q39810065 | ||
| The anaphase promoting complex is required for memory function in mice | Q43760046 | ||
| MicroRNA loss enhances learning and memory in mice | Q48174132 | ||
| DIANA-mirPath: Integrating human and mouse microRNAs in pathways | Q62666793 | ||
| P433 | issue | 20 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dementia | Q83030 |
| microRNA | Q310899 | ||
| P304 | page(s) | 4299-4308 | |
| P577 | publication date | 2011-09-23 | |
| P1433 | published in | The EMBO Journal | Q1278554 |
| P1476 | title | microRNA-34c is a novel target to treat dementias | |
| P478 | volume | 30 |
| Q90574790 | A combined miRNA-piRNA signature to detect Alzheimer's disease |
| Q92559936 | A microRNA signature of toxic extrasynaptic N-methyl-D-aspartate (NMDA) receptor signaling |
| Q35194634 | A network of RNA and protein interactions in Fronto Temporal Dementia |
| Q49113854 | A nutrigenomics approach for the study of anti-aging interventions: olive oil phenols and the modulation of gene and microRNA expression profiles in mouse brain |
| Q37122270 | A study of small RNAs from cerebral neocortex of pathology-verified Alzheimer's disease, dementia with lewy bodies, hippocampal sclerosis, frontotemporal lobar dementia, and non-demented human controls. |
| Q34061489 | Adult-specific functions of animal microRNAs |
| Q58776757 | Alterations in the MicroRNA of the Blood of Autism Spectrum Disorder Patients: Effects on Epigenetic Regulation and Potential Biomarkers |
| Q54722624 | Alzheimer's Disease: Insights from Genetic Mouse Models and Current Advances in Human IPSC-Derived Neurons. |
| Q36193841 | Alzheimer's disease models and functional genomics-How many needles are there in the haystack? |
| Q37280174 | Alzheimer's disease: presence and role of microRNAs |
| Q30587469 | Amygdala-dependent fear memory consolidation via miR-34a and Notch signaling |
| Q27007056 | Antisense oligonucleotides: treating neurodegeneration at the level of RNA |
| Q38481462 | Are microRNAs the Molecular Link Between Metabolic Syndrome and Alzheimer's Disease? |
| Q41150803 | Biological networks in Parkinson's disease: an insight into the epigenetic mechanisms associated with this disease |
| Q37425682 | Changes in microRNA expression profile in hippocampus during the acquisition and extinction of cocaine-induced conditioned place preference in rats |
| Q38267387 | Common microRNAs Target Established ASD Genes |
| Q27025904 | Consolidation and translation regulation |
| Q35911210 | Converging miRNA functions in diverse brain disorders: a case for miR-124 and miR-126. |
| Q38041425 | Decoding the non-coding RNAs in Alzheimer's disease |
| Q57471880 | Deregulation of neuronal miRNAs induced by amyloid-β or TAU pathology |
| Q35905253 | Distinct cognitive effects and underlying transcriptome changes upon inhibition of individual miRNAs in hippocampal neurons. |
| Q38612032 | Dysregulation and diagnostic potential of microRNA in Alzheimer's disease |
| Q27340506 | Early mechanisms of pathobiology are revealed by transcriptional temporal dynamics in hippocampal CA1 neurons of prion infected mice |
| Q21558421 | Emerging role of non-coding RNA in neural plasticity, cognitive function, and neuropsychiatric disorders |
| Q33858861 | Epigenetic mechanisms during ageing and neurogenesis as novel therapeutic avenues in human brain disorders. |
| Q36405886 | Epigenetic mechanisms governing the process of neurodegeneration |
| Q97570185 | Epigenetic mechanisms in Alzheimer's disease |
| Q34323841 | Epigenetic memory: the Lamarckian brain |
| Q90467945 | Epigenetic modulation during hippocampal development |
| Q39090345 | Epigenetics in Alzheimer's Disease: Perspective of DNA Methylation |
| Q26772028 | Epigenetics of Aging and Alzheimer's Disease: Implications for Pharmacogenomics and Drug Response |
| Q36956287 | Epigenetics: a novel therapeutic approach for the treatment of Alzheimer's disease |
| Q36211443 | Exosome-mediated shuttling of microRNA-29 regulates HIV Tat and morphine-mediated neuronal dysfunction. |
| Q28079218 | Exploring Biomarkers for Alzheimer's Disease |
| Q42376495 | Expression of microRNA-34a in Alzheimer's disease brain targets genes linked to synaptic plasticity, energy metabolism, and resting state network activity |
| Q38094638 | Generating new neurons to circumvent your fears: the role of IGF signaling. |
| Q38664137 | Genetic and epigenetic alterations of microRNAs and implications for human cancers and other diseases |
| Q90604684 | Genetic networks in Parkinson's and Alzheimer's disease |
| Q34413899 | Genetic variation in hippocampal microRNA expression differences in C57BL/6 J X DBA/2 J (BXD) recombinant inbred mouse strains |
| Q37342843 | Genome-wide identification and functional analyses of microRNA signatures associated with cancer pain |
| Q28079707 | Getting miRNA Therapeutics into the Target Cells for Neurodegenerative Diseases: A Mini-Review |
| Q47913817 | HDAC1 regulates fear extinction in mice. |
| Q64112575 | Human Brain Injury and miRNAs: An Experimental Study |
| Q48284060 | Hypothalamic miR-103 protects from hyperphagic obesity in mice. |
| Q33818129 | Hypoxia induces downregulation of soluble guanylyl cyclase β1 by miR-34c-5p |
| Q41444071 | IGF-1 deficiency in a critical period early in life influences the vascular aging phenotype in mice by altering miRNA-mediated post-transcriptional gene regulation: implications for the developmental origins of health and disease hypothesis. |
| Q50231813 | Icariine Restores LPS-Induced Bone Loss by Downregulating miR-34c Level |
| Q41539143 | Identification of the miRNA targetome in hippocampal neurons using RIP-seq |
| Q37549962 | Increased microRNA-34c abundance in Alzheimer's disease circulating blood plasma |
| Q26829772 | Insect microRNAs: biogenesis, expression profiling and biological functions |
| Q42251432 | Intact p53-dependent responses in miR-34-deficient mice. |
| Q36166587 | Integrating network, sequence and functional features using machine learning approaches towards identification of novel Alzheimer genes |
| Q51763074 | Into the Fourth Dimension: Dysregulation of Genome Architecture in Aging and Alzheimer's Disease. |
| Q34332494 | K-Lysine acetyltransferase 2a regulates a hippocampal gene expression network linked to memory formation |
| Q50988304 | Learning and memory: Small molecule, big hindrance to memory |
| Q48387101 | Long-term Neuroglial Cocultures as a Brain Aging Model: Hallmarks of Senescence, MicroRNA Expression Profiles, and Comparison With In Vivo Models |
| Q92104807 | Meta-Analysis of Gene Expression and Identification of Biological Regulatory Mechanisms in Alzheimer's Disease |
| Q92734272 | MiR-124 suppression in the prefrontal cortex reduces depression-like behavior in mice |
| Q37261417 | MiR-26b, upregulated in Alzheimer's disease, activates cell cycle entry, tau-phosphorylation, and apoptosis in postmitotic neurons |
| Q21129476 | Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disorders |
| Q39103202 | MicroRNA Biomarkers in Neurodegenerative Diseases and Emerging Nano-Sensors Technology. |
| Q48209471 | MicroRNA expression signature of methamphetamine use and addiction in the rat nucleus accumbens. |
| Q38323084 | MicroRNA regulation of the synaptic plasticity-related gene Arc. |
| Q38038469 | MicroRNA regulatory networks and human disease |
| Q34345924 | MicroRNA-122 down-regulation is involved in phenobarbital-mediated activation of the constitutive androstane receptor |
| Q34324544 | MicroRNA-125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer's disease |
| Q38455718 | MicroRNA-182 regulates amygdala-dependent memory formation |
| Q48506898 | MicroRNA-34 Contributes to the Stress-related Behavior and Affects 5-HT Prefrontal/GABA Amygdalar System through Regulation of Corticotropin-releasing Factor Receptor 1. |
| Q38832895 | MicroRNA-34c Downregulation Ameliorates Amyloid-β-Induced Synaptic Failure and Memory Deficits by Targeting VAMP2. |
| Q37720079 | MicroRNA-34c is regulated by p53 and is involved in sevoflurane-induced apoptosis in the developing rat brain potentially via the mitochondrial pathway |
| Q26744408 | MicroRNA: Small RNA mediators of the brains genomic response to environmental stress |
| Q36833449 | MicroRNAs and Drug Addiction |
| Q38202497 | MicroRNAs and Molecular Mechanisms of Neurodegeneration. |
| Q38048423 | MicroRNAs and neurodegeneration: role and impact |
| Q38241164 | MicroRNAs and synaptic plasticity--a mutual relationship |
| Q35714517 | MicroRNAs and their roles in aging. |
| Q27013998 | MicroRNAs as biomarkers for CNS disease |
| Q34394249 | MicroRNAs as the cause of schizophrenia in 22q11.2 deletion carriers, and possible implications for idiopathic disease: a mini-review |
| Q38843644 | MicroRNAs in Neurocognitive Dysfunctions: New Molecular Targets for Pharmacological Treatments? |
| Q36602107 | MicroRNAs in age-related diseases |
| Q36589809 | MicroRNAs in neuronal function and dysfunction |
| Q38033846 | MicroRNAs shape the neuronal landscape |
| Q33640951 | MicroRNAs: new insights into the pathogenesis of endodontic periapical disease |
| Q64234430 | Micromanaging aerobic respiration and glycolysis in cancer cells |
| Q38715316 | Missing link between microRNA and prostate cancer. |
| Q30352890 | NIH workshop report on the trans-agency blood-brain interface workshop 2016: exploring key challenges and opportunities associated with the blood, brain and their interface. |
| Q27317675 | Neurobehavioral Alterations in a Genetic Murine Model of Feingold Syndrome 2 |
| Q92971450 | Nicotinamide mononucleotide (NMN) supplementation promotes anti-aging miRNA expression profile in the aorta of aged mice, predicting epigenetic rejuvenation and anti-atherogenic effects |
| Q64998505 | Non-coding RNA influences in dementia. |
| Q38051212 | Non-coding RNAs in Alzheimer's disease |
| Q89419879 | Noncoding RNAs in disease |
| Q50130748 | Nucleic Acid-Based Theranostics for Tackling Alzheimer's Disease |
| Q34539068 | Nutrigenomics of extra-virgin olive oil: A review. |
| Q41896801 | Oxidative stress mediated-alterations of the microRNA expression profile in mouse hippocampal neurons |
| Q38843518 | Pharmacomodulation of microRNA Expression in Neurocognitive Diseases: Obstacles and Future Opportunities |
| Q38371636 | Plasticity-related microRNA and their potential contribution to the maintenance of long-term potentiation |
| Q57074830 | Potential Roles of microRNAs in the Regulation of Monoamine Oxidase A in the Brain |
| Q48020770 | Potential of microRNAs as novel targets in the alleviation of pathological fear |
| Q34045195 | Prediction of miRNA-mRNA associations in Alzheimer's disease mice using network topology |
| Q39439759 | Preliminary evidence for association of genetic variants in pri-miR-34b/c and abnormal miR-34c expression with attention deficit and hyperactivity disorder. |
| Q38601691 | Presenilin1/γ-secretase protects neurons from glucose deprivation-induced death by regulating miR-212 and PEA15. |
| Q33567669 | Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson's diseases correlate with disease status and features of pathology |
| Q36448550 | Quantification and Gene Expression Analysis of Histone Deacetylases in Common Bean during Rust Fungal Inoculation |
| Q47235112 | Quantification of distinct let-7 microRNA family members by a modified stem-loop RT-qPCR. |
| Q33746283 | RNA metabolism in neurodegenerative disease. |
| Q34660735 | Rapid regulation of microRNA following induction of long-term potentiation in vivo |
| Q37462469 | Regulation of SIRT1 by microRNAs |
| Q45793667 | Regulatory role of miRNAs in polyamine gene expression in the prefrontal cortex of depressed suicide completers |
| Q35422454 | Releasing a tiny molecular brake may improve memory |
| Q30833366 | Revisiting adult neurogenesis and the role of erythropoietin for neuronal and oligodendroglial differentiation in the hippocampus |
| Q47839085 | Role of miR-34c in ketamine-induced neurotoxicity in neonatal mice hippocampus |
| Q47712089 | Role of miR-34c in the cognitive function of epileptic rats induced by pentylenetetrazol. |
| Q47852385 | Selective inhibition of miR-92 in hippocampal neurons alters contextual fear memory |
| Q102075459 | Silencing of long non-coding RNA LINC01270 inhibits esophageal cancer progression and enhances chemosensitivity to 5-fluorouracil by mediating GSTP1methylation |
| Q58707338 | Sirtuins in Neuroendocrine Regulation and Neurological Diseases |
| Q39440775 | Stress-induced changes in miRNA biogenesis and functioning |
| Q35137389 | Studying the system-level involvement of microRNAs in Parkinson's disease |
| Q50440796 | Synaptic Dysfunction in Alzheimer's Disease: Aβ, Tau, and Epigenetic Alterations. |
| Q34339730 | Temporal profiling of gene networks associated with the late phase of long-term potentiation in vivo |
| Q54984835 | The Challenges and Opportunities in the Clinical Application of Noncoding RNAs: The Road Map for miRNAs and piRNAs in Cancer Diagnostics and Prognostics. |
| Q59798711 | The Epigenetics of Alzheimer’s Disease: Factors and Therapeutic Implications |
| Q35966911 | The Path to microRNA Therapeutics in Psychiatric and Neurodegenerative Disorders |
| Q51760979 | The Role of microRNAs in Alzheimer's Disease and Their Therapeutic Potentials. |
| Q38364827 | The biomarker and therapeutic potential of miRNA in Alzheimer's disease. |
| Q35076344 | The emerging role of microRNAs in Alzheimer's disease |
| Q34426210 | The epigenetic dimension of Alzheimer's disease: causal, consequence, or curiosity? |
| Q38527233 | The epigenetics of aging and neurodegeneration. |
| Q27024466 | The interplay between microRNAs and histone deacetylases in neurological diseases |
| Q35889746 | The microRNA miR-34 modulates ageing and neurodegeneration in Drosophila |
| Q38210767 | The p53/miR-34 axis in development and disease |
| Q36238203 | The physiological impact of microRNA gene regulation in the retina |
| Q38237430 | The role of epigenetics in cognitive ageing |
| Q38310488 | Thinking small: towards microRNA-based therapeutics for anxiety disorders |
| Q35665925 | Type 2 Diabetes Monocyte MicroRNA and mRNA Expression: Dyslipidemia Associates with Increased Differentiation-Related Genes but Not Inflammatory Activation |
| Q33738316 | Widespread microRNA dysregulation in multiple system atrophy - disease-related alteration in miR-96. |
| Q48166883 | miR-135a Regulates Synaptic Transmission and Anxiety-Like Behavior in Amygdala. |
| Q92135423 | miR-155-5p Promotes Dorsal Root Ganglion Neuron Axonal Growth in an Inhibitory Microenvironment via the cAMP/PKA Pathway |
| Q47608479 | miR-181a Participates in Contextual Fear Memory Formation Via Activating mTOR Signaling Pathway |
| Q38641480 | miR-181a involves in the hippocampus-dependent memory formation via targeting PRKAA1. |
| Q54942568 | miR-182-5p and miR-183-5p Act as GDNF Mimics in Dopaminergic Midbrain Neurons. |
| Q36665462 | miR-204 downregulates EphB2 in aging mouse hippocampal neurons |
| Q35487610 | miR-26a and miR-384-5p are required for LTP maintenance and spine enlargement. |
| Q92715034 | miR-26b inhibits total neurite outgrowth, promotes cells apoptosis and downregulates neprilysin in Alzheimer's disease |
| Q64860049 | miR-34a/BCL-2 signaling axis contributes to apoptosis in MPP+ -induced SH-SY5Y cells |
| Q49458188 | miR-34c-5p functions as pronociceptive microRNA in cancer pain by targeting Cav2.3 containing calcium channels |
| Q34446986 | miRNA regulons associated with synaptic function |
| Q58795107 | miRNA-34c Overexpression Causes Dendritic Loss and Memory Decline |
| Q34324509 | miRNAs at the interface of cellular stress and disease |
| Q39403789 | microRNA in Cardiovascular Aging and Age-Related Cardiovascular Diseases |
| Q50568042 | microRNAs Modulate Spatial Memory in the Hippocampus and in the Ventral Striatum in a Region-Specific Manner. |
| Q55231712 | microRNAs in Neurodegeneration: Current Findings and Potential Impacts. |
| Q47564833 | microRNAs in Parkinson's Disease: From Pathogenesis to Novel Diagnostic and Therapeutic Approaches. |
Search more.